Skip to content

Released Jul 30, 2012

10-Q filed Jul 30, 2012, 30 days after period end · 0001104659-12-052296

Q2 2012 · 10-Q
Revenue$111.60M+3.1% vs Q2 2011+4.1% vs Q1 2012
Net Income$8.80M+63.2% vs Q2 2011+19.8% vs Q1 2012
EPS Diluted$0.46+58.6% vs Q2 2011+21.1% vs Q1 2012
Gross Profit$86,658,000+1.4%
Operating Income$16,622,000+34.5%
Operating Cash Flowderived$8,790,000+90.1%
Free Cash Flowderived$2,368,000N/M
Margins · derived
Gross margin77.6%−1.3 pt vs Q2 2011
Operating margin14.9%+3.5 pt vs Q2 2011
Net margin7.9%+2.9 pt vs Q2 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2012Q2 2011Q2 2010
Revenue$111.60M$108.22M$142.85M
Net Income$8.80M$5.40M$10.23M
EPS Diluted$0.46$0.29$0.57

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR